Tørpulverformulering omfattende en phosphodiesterase-hæmmer
The invention relates to a pharmaceutical formulation in the form of inhalable dry powder comprising particles of a phosphodiesterase-4 inhibitor as active ingredient. The invention also relates to the process for the preparation thereof, and to its use in the prevention and/or treatment of a respir...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | dan |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | The invention relates to a pharmaceutical formulation in the form of inhalable dry powder comprising particles of a phosphodiesterase-4 inhibitor as active ingredient. The invention also relates to the process for the preparation thereof, and to its use in the prevention and/or treatment of a respiratory disease such as asthma and COPD. |
|---|